ScholarIQanswers from OpenAlex

Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease

PaperCitations, authors & open-access status

Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease have?

ScholarIQcitation count

Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease has 177 citations in the OpenAlex counts ScholarIQ stores.

When was Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease published?

ScholarIQyear

Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease has 2003 year in the ScholarIQ index.

What is the open-access status of Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease?

ScholarIQoa status

Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease has bronze oa status in the ScholarIQ index.

What is the DOI of Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease?

ScholarIQdoi

The DOI for Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease is on the source record.

What is the PMID of Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease?

ScholarIQpmid

The PMID for Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease is on the source record.

What is the OpenAlex record for Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease?

ScholarIQopenalex

The OpenAlex for Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial